Reactions of Hydroxymethyl Phosphines
J. Am. Chem. Soc., Vol. 121, No. 8, 1999 1659
and gly-gly-gly were obtained from Sigma Chemical Co. Diethylamine
and N-methylaniline were obtained from Aldrich Chemical Co. All
commercial reagents were used as received. The synthesis of THP (1),20
HMPB (2),21 and HMPE (3)22 has been previously described. Waters
Sep-Pak Vac C18 columns (10 g, 35 mL) were obtained from Fisher
Scientific Co.
Nuclear magnetic resonance spectra were recorded on a Bruker ARX-
300 spectrometer. The 1H and 13C chemical shifts are reported relative
to an external standard of TMS, and 31P NMR chemical shifts are
reported to an external standard of 85% H3PO4.
Scheme 1. Reaction of THP (1) with Amines
shown to stabilize biologically active conformations, enhance
structural integrity, and thereby promote new enzymatic activi-
ties.12
Since phosphines display versatile coordination chemistry
with transition metals and radiometals, phosphine-containing
peptides (or peptide-avid biomolecules) have gained importan-
tance in the design and development of tumor-specific radio-
pharmaceuticals.13-17 Despite the significant utility offered by
phosphine-containing peptides (and proteins), synthetic strategies
of producing such bioconjugates are still in infancy. The elegant
work by Gilbertson and co-workers on the incorporation of aryl
and cyclohexyl phosphines on specific peptides has provided
impetus to this burgeoning field of chemical and biomedical
sciences.18
From the aforementioned discussions, it is clear that the model
reaction, outlined in Scheme 1, can be used in multiple appli-
cations in chemistry, biochemistry, and biomedical sciences.
Therefore, a detailed understanding of the fundamental organic
chemistry of the reactions of hydroxymethylphosphines with
amines and amino acids will further aid the applications of these
reactions in chemical and biomedical sciences. As part of our
studies involving the development of new bioconjugates,19 we
have undertaken a systematic investigation of the reactions of
(a) tris(hydroxymethyl)phosphine (THP, 1), (b) 1,2-bis[bis-
(hydroxymethyl)phosphino]benzene (HMPB, 2), and (c) 1,2-
bis[bis(hydroxymethyl)phosphino]ethane (HMPE, 3) with primary/
secondary amines, amino acids, and model peptides. We, herein,
report isolation and full characterization of phosphine-amine
(or amino acid) and peptide conjugates and also X-ray structures
of several of the amino acid-phosphine conjugates: (i) mono-
phosphine (THP)-glycine conjugate, (ii) bisphosphine (HMPB)-
N-methylaniline conjugate, (iii) bisphosphine (HMPB)-glycine
conjugate, and (iv) bisphosphine (HMPE)-glycine conjugate.
These are the first examples of structurally characterized hy-
droxymethyphosphine-amino acid linkages, and they provide,
for the first time, definite evidence for the Mannich-type of
addition of -CH2OH groups with -NH2 groups as discussed
in the following sections
High-pressure liquid chromatography (HPLC) analyses and separa-
tions were performed using a Waters 600 dual-pump system equipped
with a 486 tunable absorbance detector and a 746 data module. Standard
reverse phase HPLC separations were performed on a C18 column
(Whatman Partisil 10 ODS-3 (9.5 × 500 mm)) using a gradient mobile
phase with solvent A composed of 0.1% trifluoroacetic acid in 3:1
acetonitrile/water mixture and solvent B composed of 0.1% trifluoro-
acetic acid in water. The gradient used is as follows: 0-3 min 2% A,
98% B; 3-18 min linear gradient to 100% A; 18-20 min 100% A;
20-30 min linear gradient to 2% A, 98% B. The flow rate and
wavelength were set to 4 mL/min and 254 nm; respectively. Mass
spectral analyses were performed by the Washington University
Resource for Biomedical and Bio-organic Mass Spectrometry, St. Louis,
Missouri. Elemental analyses were performed by Oneida Research
Services, Inc. Whitesboro, New York. Melting points were determined
on Mel-Temp II apparatus and are uncorrected.
2-Di(carboxymethylaminomethyl)phosphanylmethylamino-
acetic Acid (4). Tris(hydroxymethyl)phosphine (0.933 g, 7.52 mmol)
in 10 mL of distilled water was added dropwise to glycine (0.282 g,
3.76 mmol) in water (10 mL) at 25 °C. The reaction was stirred
under dry nitrogen for 3 h. The product was filtered off and dried
in vacuo to give the analytically pure compound in 82% yield as a
white solid. Anal. Calcd for C9H18N3O6P‚H2O: C, 34.49; H, 6.44;
N,13.42. Found: C, 32.75; H, 6.34; N, 13.14. HRFAB calcd for
[M + H]+ 295.0933, found 296.1011. Mp 202-204 °C dec. 1H NMR
(D2O, NaOD): δ 2.70 (s, 6H, NCH2COOH), 3.04 (s, 6H, PCH2N).
13C NMR (D2O, NaOD): δ 44.55 (d, NCH2COOH, J ) 5.21 Hz), 53.50
(d, PCH2N, J ) 9.96 Hz), 179.14 (s). 31P NMR (D2O, NaOD): δ
-38.1 (s).
1,2-Di[di(methylanilinomethyl)phosphanyl]benzene (5). N-meth-
ylaniline (0.453 g, 4.23 mmol) was added dropwise to 1,2-bis[bis(hy-
droxymethyl)phosphino]benzene (0.222 g, 0.850 mmol) in ethanol (5
mL) at 25 °C. The reaction was stirred under dry nitrogen for 1 h. The
product was filtered off and dried in vacuo to give the analytically
pure compound in 90% yield as a white solid. Anal. Calcd for
C38H44N4P2: C, 73.76; H, 7.17; N, 9.05. Found: C, 73.60; H, 7.05; N,
9.02. HRFAB calcd for C38H44N4P2 [M + H]+ 618.3041, found
1
619.3095. Mp 88-90 °C. H NMR (CDCl3): δ 2.76 (s, 12H, NCH3),
Experimental Section
3.83 (m, 8H, PCH2N), 6.63-6.68 (m, 12H, MeNC6H5-o,p), 7.07-7.19
(m, 8H, MeNC6H5-m), 7.39-7.44 (m, 2H, PC6H4-m), 7.59-7.64 (m,
2H, PC6H4-o). 13C (CDCl3) NMR: δ 39.2 (virtual triplet, NCH3, J )
6.7 Hz), 53.8 (virtual triplet, PCH2N, J ) 9.1 Hz), 113.4 (t, J ) 1.2
Hz), 116.9 (s), 128.9 (s), 129.4 (s), 131.3 (t, J ) 3.8 Hz), 143.9 (t, J
) 5.3 Hz), 149.4 (s). 31P (CDCl3) NMR: δ -43.6 (s).
All reactions were carried out under purified nitrogen by standard
Schlenk techniques. Solvents were purified and dried by standard
methods and distilled under nitrogen prior to use. Glycine, alanine,
(12) (a) Iverson, B. L.; Iverson, S. A.; Roberts, V. A.; Getzoff, E. D.;
Tainer, J. A.; Benkovic, S. J.; Lerner, R. A. Science 1990, 249, 659-662.
(b) Regan, L. Annu. ReV. Biophys. Biomol. Struct. 1993, 22, 257-281. (c)-
Kellis, J. T., Jr.; Todd, R. J.; Arnold, F. H. Biotechnology 1991, 9, 994-
995.
(13) DeRosch, M. A.; Brodack, J. W.; Grummon, G. D.; Marmion, M.
E.; Nosco, D. L.; Deutsch, K. F.; Deutsch, E. J. Nucl. Med. 1992, 33, 850.
(14) Dilworth, J. R; Parrott, S. J. Chem. Soc. ReV. 1998, 27, 43-55.
(15) Berning D. E.; Katti K. V.; Volkert W. A. unpublished results.
(16) Berning D. E.; Katti K. V.; Volkert W. A.; Higginbotham, C. J.;
Ketring, A. R. Nucl. Med. Biol. 1998, 25, 577-583.
1,2-Di[di(ethylaminomethyl)phosphanyl]benzene (6). Diethyl-
amine (3.00 g, 41.0 mmol) was added dropwise to 1,2-bis[bis(hy-
droxymethyl)phosphino]benzene (2.56 g, 9.77 mmol) in ethanol (10
mL) at 25 °C. The reaction was stirred under dry nitrogen for 1 h. The
solvent and excess diethylamine were removed in vacuo to obtain a
viscous oil. The residue was suspended in water (10 mL) and extracted
with CH2Cl2 (3 × 10 mL). The combined organic fractions were
concentrated to approximately 10 mL and purified on a silica gel column
to give the analytically pure product in 62% yield. Anal. Calcd for
(17) For recent references on the design and development of tumor-
specific radiopharmaceuticals, see: (a) McAffe, J. G.; Neumann, R. D. Nucl.
Med. Biol. 1996, 23, 673-676. (b) Lister-James, J.; Moyer, B. R.; Dean,
R. T. Q. J. Nucl. Med. 1996, 40, 221-233. (c) Lui, S.; Edwards, D. S.;
Barrett, J. A.; Bioconjugate Chem. 1997, 8, 621-636. (d) Fischmann, A.
J.; Babich, J. W.; Strauss, D. J. Nucl. Med. 1993, 34, 2253-2263.
(18) (a) Gilbertson S. R.; Chen G.; McLoughlin, M. J. Am. Chem Soc.
1994, 116, 4481-4482. (b) Gilbertson S. R.; Wang X.; Hoge G. S.; Klug
C. A.; Schaefer J. Organometallics 1996, 15, 4678-4680.
(20) (a) Ellis, J. W.; Harrison, K. N.; Hoye, P. A. T.; Orpen, A. G.;
Pringle, P. G.; Smith, M. B. Inorg. Chem. 1992, 31, 3026-3033. (b) Hoye,
P. A. T.; Pringle, P. G.; Smith, M. B.; Worboys, K. J. Chem. Soc., Dalton
Trans. 1993, 269-274.
(21) Reddy, V. S.; Katti, K. V.; Barnes, C. L. J. Chem. Soc., Dalton
Trans. 1996, 1301-1304.
(22) Reddy, V. S.; Katti, K. V.; Barnes, C. L. Inorg. Chim. Acta 1995,
240, 367-370.
(19) Katti, K. V.; Hariprasad, G.; Smith, C. J.; Berning, D. E. Acc. Chem.
Res. 1999, 32, 9-17.